Endovascular brachytherapy using (125)I seeds strand combined with transarterial chemoembolization, lenvatinib, and camrelizumab for unresectable hepatocellular carcinoma with hepatic vein tumor thrombus.
- DOI
- 10.1016/j.brachy.2026.09.003
- Published
- 2026 Nov 2
- Container
- Brachytherapy
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.brachy.2026.09.003,
title = {Endovascular brachytherapy using (125)I seeds strand combined with transarterial chemoembolization, lenvatinib, and camrelizumab for unresectable hepatocellular carcinoma with hepatic vein tumor thrombus.},
author = {Li M and Wan JC and Zhang W and Yan ZP and Qu XD and Zhang ZH},
year = {2026},
journal = {Brachytherapy},
doi = {10.1016/j.brachy.2026.09.003},
url = {https://doi.org/10.1016/j.brachy.2026.09.003}
}RIS
TY - JOUR TI - Endovascular brachytherapy using (125)I seeds strand combined with transarterial chemoembolization, lenvatinib, and camrelizumab for unresectable hepatocellular carcinoma with hepatic vein tumor thrombus. AU - Li M AU - Wan JC AU - Zhang W AU - Yan ZP AU - Qu XD AU - Zhang ZH PY - 2026 JO - Brachytherapy DO - 10.1016/j.brachy.2026.09.003 UR - https://doi.org/10.1016/j.brachy.2026.09.003 ER -
APA
M, L., JC, W., W, Z., ZP, Y., XD, Q., & ZH, Z. (2026). Endovascular brachytherapy using (125)I seeds strand combined with transarterial chemoembolization, lenvatinib, and camrelizumab for unresectable hepatocellular carcinoma with hepatic vein tumor thrombus.. Brachytherapy. https://doi.org/10.1016/j.brachy.2026.09.003
Source records
- pubmed · retrieved 2026-11-10T09:53:24.162Z